BridgeMD
New treatment option for Stroke Rehabilitation
Official title Music Therapy for Rehabilitation in Post-stroke Non-fluent Aphasia: the Indian Adaptation
ClinicalTrials.gov ID: NCT06323330
What this study is testing
- What it's testing
- The goal of this Interventional Study is to develop and test the Indian Adaptation of Melodic Intonation Therapy (MIT) for Indian patients in with post-stroke Non-Fluent Aphasia (PSNFA). The main question(s) it aims to answer are: To develop the MIT Indian Adaptation tool and check its feasibility To compare the MIT with standard speech rehabilitation in patient with PSNFA.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 99
You may be able to join if
- All of the following
- Age ≥18 years of age
- Stroke with non-fluent aphasia, within one year of ictus
- Imaging evidence suggestive of ischemic or hemorrhagic stroke of dominant hemisphere
- Patient is alert and able to follow simple commands (should not have global aphasia)
You likely can't join if
- Any of the following:
- Patients with a history of a previous stroke other than the index event, which can explain the aphasia.
- Any clinical condition (e.g., short life expectancy, coexisting disease) or other characteristics that preclude appropriate follow-up in the study...
- Patients participating in any therapeutic intervention clinical trials evaluating poststroke recovery
- Use of psychotropic drugs that interfere with patient evaluation
See the full eligibility criteria
- All of the following
- Age ≥18 years of age
- Stroke with non-fluent aphasia, within one year of ictus
- Imaging evidence suggestive of ischemic or hemorrhagic stroke of dominant hemisphere
- Patient is alert and able to follow simple commands (should not have global aphasia)
- Motivated caregiver
- Informed and signed consent
- Any of the following:
- Patients with a history of a previous stroke other than the index event, which can explain the aphasia.
- Any clinical condition (e.g., short life expectancy, coexisting disease) or other characteristics that preclude appropriate follow-up in the study (e.g., distant residence, no family support)
- Patients participating in any therapeutic intervention clinical trials evaluating poststroke recovery
- Use of psychotropic drugs that interfere with patient evaluation
The study team makes the final eligibility decision.
Where it's taking place
- New Delhi, National Capital Territory of Delhi, India
- Delhi, India
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 99 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New Delhi, National Capital Territory of Delhi, India; Delhi, India. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.